| S/N | TITLE | DESCRIPTION | START DATE | END DATE | FUNDER | INVESTIGATOR |
|---|---|---|---|---|---|---|
| 1 | Advancing Capacity for Early Phase Trials for Pandemics and Epidemics in Africa (ACCEPT-Africa) | ACCEPT-Africa strengthens Africa’s capacity to conduct Phase I and III trials for emerging infectio… | None | None | Mastercard Foundation (EPSILON Initiative) | Prof. Stellah Mpagama |
| 2 | Empowering Pandemic Preparedness in Tanzania | This consortium strengthens Tanzania’s pandemic preparedness through: One-Health pathogen survei… | None | None | World Bank Pandemic Fund Project | None |
| 3 | Integrated Tuberculosis and Respiratory Care in Africa (iTARA) | iTARA uses mixed methods to develop a framework for integrated TB and chronic respiratory disease c… | April 1, 2022 | Dec. 31, 2027 | NIHR (UK) | Prof. Stellah Mpagama |
| 4 | Silicosis and Silicotuberculosis Among Small-Scale Tanzanite Miners in Northern Tanzania (SILICO TB) | SilicoTB investigates occupational respiratory diseases among small-scale gemstone miners in Northe… | None | None | Medical Research Council (UK) | Dr Bibie Said |
| 5 | Early Empiric Anti-TB Therapy for Sepsis in Sub-Saharan Africa (ATLAS Trial) | The ATLAS trial is a phase III randomized, 2x2 factorial multi-site study conducted in Tanzania and… | April 1, 2024 | Dec. 31, 2027 | NIH (USA) | Prof. Stellah Mpagama |
| 6 | Research Capacity Strengthening for (Re)-Emerging Infectious Diseases in Tanzania (REMODEL_TZ) | REMODEL_TZ combined clinical research with structured capacity building to strengthen Tanzania’s pr… | None | None | EDCTP Senior Research Fellowship | Prof. Stellah Mpagama |
| 7 | A Pragmatic Trial with Optimized Dose of Rifampicin and Moxifloxacin for Drug-Susceptible Pulmonary Tuberculosis (OptiRiMoxTB) | The OptiRiMoxTB study is a multi-country, Phase III randomized controlled clinical trial evaluating… | April 1, 2022 | Dec. 31, 2026 | EDCTP_2 | Prof. Stellah Mpagama |